Cargando…

Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies

Detalles Bibliográficos
Autores principales: Bangs, Mark E., Kudrow, David, Wang, Shufang, Oakes, Tina M., Terwindt, Gisela M., Magis, Delphine, Yunes-Medina, Laura, Stauffer, Virginia L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068985/
https://www.ncbi.nlm.nih.gov/pubmed/32169042
http://dx.doi.org/10.1186/s12883-020-01675-7
_version_ 1783505686529835008
author Bangs, Mark E.
Kudrow, David
Wang, Shufang
Oakes, Tina M.
Terwindt, Gisela M.
Magis, Delphine
Yunes-Medina, Laura
Stauffer, Virginia L.
author_facet Bangs, Mark E.
Kudrow, David
Wang, Shufang
Oakes, Tina M.
Terwindt, Gisela M.
Magis, Delphine
Yunes-Medina, Laura
Stauffer, Virginia L.
author_sort Bangs, Mark E.
collection PubMed
description
format Online
Article
Text
id pubmed-7068985
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70689852020-03-18 Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies Bangs, Mark E. Kudrow, David Wang, Shufang Oakes, Tina M. Terwindt, Gisela M. Magis, Delphine Yunes-Medina, Laura Stauffer, Virginia L. BMC Neurol Correction BioMed Central 2020-03-13 /pmc/articles/PMC7068985/ /pubmed/32169042 http://dx.doi.org/10.1186/s12883-020-01675-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Bangs, Mark E.
Kudrow, David
Wang, Shufang
Oakes, Tina M.
Terwindt, Gisela M.
Magis, Delphine
Yunes-Medina, Laura
Stauffer, Virginia L.
Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
title Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
title_full Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
title_fullStr Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
title_full_unstemmed Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
title_short Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
title_sort correction to: safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068985/
https://www.ncbi.nlm.nih.gov/pubmed/32169042
http://dx.doi.org/10.1186/s12883-020-01675-7
work_keys_str_mv AT bangsmarke correctiontosafetyandtolerabilityofmonthlygalcanezumabinjectionsinpatientswithmigraineintegratedresultsfrommigraineclinicalstudies
AT kudrowdavid correctiontosafetyandtolerabilityofmonthlygalcanezumabinjectionsinpatientswithmigraineintegratedresultsfrommigraineclinicalstudies
AT wangshufang correctiontosafetyandtolerabilityofmonthlygalcanezumabinjectionsinpatientswithmigraineintegratedresultsfrommigraineclinicalstudies
AT oakestinam correctiontosafetyandtolerabilityofmonthlygalcanezumabinjectionsinpatientswithmigraineintegratedresultsfrommigraineclinicalstudies
AT terwindtgiselam correctiontosafetyandtolerabilityofmonthlygalcanezumabinjectionsinpatientswithmigraineintegratedresultsfrommigraineclinicalstudies
AT magisdelphine correctiontosafetyandtolerabilityofmonthlygalcanezumabinjectionsinpatientswithmigraineintegratedresultsfrommigraineclinicalstudies
AT yunesmedinalaura correctiontosafetyandtolerabilityofmonthlygalcanezumabinjectionsinpatientswithmigraineintegratedresultsfrommigraineclinicalstudies
AT stauffervirginial correctiontosafetyandtolerabilityofmonthlygalcanezumabinjectionsinpatientswithmigraineintegratedresultsfrommigraineclinicalstudies